Forbion Capital Fund IV Cooperatief U.A. - 31 Mar 2025 SCHEDULE 13G/A Report for Dyne Therapeutics, Inc. Common Stock, par value $0.0001 (DYN)

Filing Manager
Forbion Capital Fund IV Cooperatief U.A.
Reporting Manager
ForDyne B.V.
Security
Dyne Therapeutics, Inc. Common Stock, par value $0.0001
Symbol
DYN
Shares outstanding
113M shares
Disclosed Ownership
5.4M shares
Ownership
4.8%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 08:46:56 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ForDyne B.V. 4.8% 5.4M 0 5.4M /s/ V. van Houten /s/ H.A. Slootweg V. van Houten and H.A. Slootweg, Directors of its Director
Forbion Capital Fund IV Cooperatief U.A. 3.6% 4.04M 0 4.04M /s/ V. van Houten /s/ H.A. Slootweg V. van Houten and H.A. Slootweg, Directors of its Director
Forbion IV Management B.V. 3.6% 4.04M 0 4.04M /s/ V. van Houten /s/ H.A. Slootweg V. van Houten and H.A. Slootweg, Directors of its Director
Forbion Growth Opportunities Fund II Cooperatief U.A. 1.3% 1.43M 0 1.43M /s/ V. van Houten /s/ H.A. Slootweg V. van Houten and H.A. Slootweg, Directors
Forbion Growth II Management B.V. 1.3% 1.43M 0 1.43M /s/ V. van Houten /s/ H.A. Slootweg V. van Houten and H.A. Slootweg, Directors